Zusammenfassung
Diverse internationale Fachgesellschaften unterstreichen inzwischen die Relevanz und das Potenzial von Sport- und Bewegungstherapie als unterstützende Ressource in der interdisziplinären onkologischen Versorgung. Bislang existieren allerdings noch keine entsprechenden Leitlinien. Die Deutsche Krebsgesellschaft hat daher nun die Arbeit an der S3-Leitlinie „Bewegungstherapie bei onkologischen Erkrankungen“ aufgenommen. Ziel dieser Guideline ist es, die Bewegungstherapie als integrativen Bestandteil einer interdisziplinären onkologischen Behandlung zu etablieren und zum abrechenbaren Standard zu machen. Die Leitlinie wird voraussichtlich Ende 2024/Anfang 2025 fertiggestellt sein.
Abstract
Various international specialist societies underline the relevance and the potential of sport and exercise therapy as a supporting resource in interdisciplinary oncological care; however, so far there are no appropriate guidelines. The German Cancer Society has therefore started the work on the S3 guideline on exercise therapy for oncological diseases. The aim of the guideline is to establish exercise therapy as an integral component of oncological treatment and to make it a billable standard. The guidelines are expected to be completed by the end of 2024 or beginning of 2025.
This is a preview of subscription content, log in via an institution to check access.
Literatur
Christensen JF, Simonsen C, Hojman P (2018) Exercise training in cancer control and treatment. Compr Physiol 9(1):165–205
Sweegers MG et al (2018) Which exercise prescriptions improve quality of life and physical function in patients with cancer during and following treatment? A systematic review and meta-analysis of randomised controlled trials. Br J Sports Med 52(8):505–513
Scott JM et al (2018) Efficacy of exercise therapy on cardiorespiratory fitness in patients with cancer: a systematic review and meta-analysis. J Clin Oncol 36(22):2297–2305
Scott JM et al (2018) Exercise therapy and cardiovascular toxicity in cancer. Circulation 137(11):1176–1191
Duregon F et al (2018) Effects of exercise on cancer patients suffering chemotherapy-induced peripheral neuropathy undergoing treatment: a systematic review. Crit Rev Oncol Hematol 121:90–100
Zimmer P et al (2016) Effects of exercise interventions and physical activity behavior on cancer related cognitive impairments: a systematic review. Biomed Res Int. https://doi.org/10.1155/2016/1820954
Winters-Stone KM et al (2014) Influence of weight training on skeletal health of breast cancer survivors with or at risk for breast cancer-related lymphedema. J Cancer Surviv 8(2):260–268
Cormie P et al (2017) The impact of exercise on cancer mortality, recurrence, and treatment-related adverse effects. Epidemiol Rev 39(1):71–92
Cormie P et al (2018) Clinical oncology society of Australia position statement on exercise in cancer care. Med J Aust 209(4):184–187
Campbell KL et al (2019) Exercise guidelines for cancer survivors: consensus statement from international multidisciplinary roundtable. Med Sci Sports Exerc 51(11):2375–2390
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Interessenkonflikt
J. Wiskemann und F. Baumann geben an die hier berichtete Leitlinie zu koordinieren.
Für diesen Beitrag wurden von den Autor/-innen keine Studien an Menschen oder Tieren durchgeführt. Für die aufgeführten Studien gelten die jeweils dort angegebenen ethischen Richtlinien.
Additional information
QR-Code scannen & Beitrag online lesen
Rights and permissions
About this article
Cite this article
Wiskemann, J., Baumann, F. Update: S3-Leitline Bewegungstherapie bei onkologischen Erkrankungen. Forum 37, 449–451 (2022). https://doi.org/10.1007/s12312-022-01142-z
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12312-022-01142-z